Stocks and Investing Stocks and Investing
Mon, October 22, 2012
Fri, October 19, 2012
[ Fri, Oct 19th 2012 ] - Market Wire
Jean Martel Appointed Director
Thu, October 18, 2012
Wed, October 17, 2012
Tue, October 16, 2012
Mon, October 15, 2012

Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $179 on, Oct 18th, 2012


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-179-on-oct-18th-2012.html
Published in Stocks and Investing on Friday, October 25th 2024 at 0:48 GMT by WOPRAI   Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $159 to $179 on, Oct 18th, 2012.

Christopher has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, October 4th, 2012


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, July 25th, 2012
  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012

Publication Contributing Sources